Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
72.34 USD | +1.51% | -0.66% | +1.48% |
Feb. 27 | Ligand Pharmaceuticals' Q4 Adjusted Earnings Rise, Revenue Falls; Reaffirms 2024 Guidance | MT |
Feb. 27 | Transcript : Ligand Pharmaceuticals Incorporated, Q4 2023 Earnings Call, Feb 27, 2024 |
- Stock
- Equities
- Stock Ligand Pharmaceuticals Incorporated - Nasdaq
- News Ligand Pharmaceuticals Incorporated